| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | 98OYR854NY |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTISENSE INHIBITOR | Transforming growth factor beta-2 mRNA antisense inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glioblastoma | 3 | D005909 | ClinicalTrials |
| Astrocytoma | 3 | D001254 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108345 |
| FDA SRS | 98OYR854NY |
CONTENTS